IDH2 and acute myeloid leukemia: Mutations in Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) were found in approximately 7–14% and 8–19% of patients with AML respectively [62] as well as in solid tumors such as glioma, chondrosarcoma and cholangiocarcinoma [63].